Joint EASL, AASLD and ILTS survey on world practice and barriers to the utilization of HBsAg-positive organs in adult recipients
In a joint effort, EASL, together with the International Liver Transplantation Society (ILTS) and the American Association for the Study of Liver Diseases (AASLD), is launching a survey aimed at transplant centres…
Call for Applications for Position of Editor-in-Chief, JHEP Reports
About JHEP Reports Published since 2019, JHEP Reports is EASL’s first open access journal with a 2021 Impact Factor of 9.917. JHEP Reports is an innovative Journal publishing articles on global issues…
Announcing future EASL Congress dates
The EASL Congress has been gathering experts from around the world to beat liver disease, since 1966. It has since become the place to be, to learn, share and interact with the…
Bringing Care to All European Patients: EASL Advocacy Events for Liver Cancer Awareness Month
This October 2022, in honour of Liver Cancer Awareness Month, EASL participated in organising two important advocacy events aimed at identifying and implementing strategies to enhance awareness of liver cancer and engage…
Liver cancer cases and deaths projected to rise by more than 55% by 2040
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people…
United Action for Better Health in Europe
On 12-14 September 2022, representatives from civil society, partnering organizations, and the 53 Member States of the WHO European Region met in Tel Aviv, Israel for the 72nd governance session. The session…
Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing…